Snowball will help you to track your portfolio, plan deposits to your brokerage account and support your passive income strategy with tools and community of investors
What sector does Jubilant Pharmova Limited (JUBLPHARMA) operate in?
Jubilant Pharmova Limited belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Jubilant Pharmova Limited (JUBLPHARMA) current stock price?
As of the latest data, Jubilant Pharmova Limited stock price is ₹1,165.70, with a previous close of ₹1,171.80. Jubilant Pharmova Limited lost -₹6.10 in the last trading session, representing a -0.52% loss.
What is Jubilant Pharmova Limited (JUBLPHARMA) current market capitalization?
Jubilant Pharmova Limited market cap is approximately 184.64 billion.
What is Jubilant Pharmova Limited (JUBLPHARMA) Earnings Per Share (EPS)?
The trailing EPS is ₹52.85, and the forward EPS is ₹33.80.
What is Jubilant Pharmova Limited (JUBLPHARMA) Price-to-Earnings (P/E) ratio?
Jubilant Pharmova Limited current P/E ratio is 22.06, with a forward P/E of 34.49.
What is Jubilant Pharmova Limited (JUBLPHARMA) EBITDA?
Jubilant Pharmova Limited EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 3.42 billion.
Does Jubilant Pharmova Limited (JUBLPHARMA) pay dividends?
Yes. Jubilant Pharmova Limited pays annual dividends with an annualized yield of 0.43% and an estimated annual payout of ₹5.00 per share.
When is the next ex-dividend date for Jubilant Pharmova Limited (JUBLPHARMA)?
The next ex-dividend date is scheduled for July 25, 2025.
How did Jubilant Pharmova Limited (JUBLPHARMA) perform in its most recent earnings report?
In the last report (March 31, 2025), Jubilant Pharmova Limited posted an EPS surprise of 15.65% and a revenue surprise of -73.32%.
When is Jubilant Pharmova Limited (JUBLPHARMA) next earnings report?
Jubilant Pharmova Limited is expected to release its next earnings report on June 30, 2025.
What is Jubilant Pharmova Limited (JUBLPHARMA) beta (volatility) score?
Jubilant Pharmova Limited has a beta of 0.803, meaning its volatility is roughly in line with the market.